AMPH
Price
$29.83
Change
-$0.38 (-1.26%)
Updated
Aug 15 closing price
Capitalization
1.39B
86 days until earnings call
HKMPF
Price
$23.96
Change
-$2.42 (-9.17%)
Updated
Aug 11 closing price
Capitalization
5.38B
Interact to see
Advertisement

AMPH vs HKMPF

Header iconAMPH vs HKMPF Comparison
Open Charts AMPH vs HKMPFBanner chart's image
Amphastar Pharmaceuticals
Price$29.83
Change-$0.38 (-1.26%)
Volume$651.99K
Capitalization1.39B
Hikma Pharmaceuticals
Price$23.96
Change-$2.42 (-9.17%)
Volume$300
Capitalization5.38B
AMPH vs HKMPF Comparison Chart in %
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMPH vs. HKMPF commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Hold and HKMPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (AMPH: $29.83 vs. HKMPF: $23.60)
Brand notoriety: AMPH and HKMPF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMPH: 121% vs. HKMPF: 193%
Market capitalization -- AMPH: $1.39B vs. HKMPF: $5.38B
AMPH [@Pharmaceuticals: Generic] is valued at $1.39B. HKMPF’s [@Pharmaceuticals: Generic] market capitalization is $5.38B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 0 FA rating(s) are green whileHKMPF’s FA Score has 1 green FA rating(s).

  • AMPH’s FA Score: 0 green, 5 red.
  • HKMPF’s FA Score: 1 green, 4 red.
According to our system of comparison, AMPH is a better buy in the long-term than HKMPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 5 TA indicator(s) are bullish while HKMPF’s TA Score has 3 bullish TA indicator(s).

  • AMPH’s TA Score: 5 bullish, 5 bearish.
  • HKMPF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, AMPH is a better buy in the short-term than HKMPF.

Price Growth

AMPH (@Pharmaceuticals: Generic) experienced а +25.28% price change this week, while HKMPF (@Pharmaceuticals: Generic) price change was -9.16% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Reported Earning Dates

AMPH is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HKMPF($5.38B) has a higher market cap than AMPH($1.39B). HKMPF has higher P/E ratio than AMPH: HKMPF (14.35) vs AMPH (11.31). HKMPF YTD gains are higher at: 1.199 vs. AMPH (-19.661). HKMPF has higher annual earnings (EBITDA): 734M vs. AMPH (259M). AMPH has more cash in the bank: 237M vs. HKMPF (127M). AMPH has less debt than HKMPF: AMPH (653M) vs HKMPF (1.31B). HKMPF has higher revenues than AMPH: HKMPF (3.22B) vs AMPH (731M).
AMPHHKMPFAMPH / HKMPF
Capitalization1.39B5.38B26%
EBITDA259M734M35%
Gain YTD-19.6611.199-1,639%
P/E Ratio11.3114.3579%
Revenue731M3.22B23%
Total Cash237M127M187%
Total Debt653M1.31B50%
FUNDAMENTALS RATINGS
AMPH vs HKMPF: Fundamental Ratings
AMPH
HKMPF
OUTLOOK RATING
1..100
2289
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
9
Undervalued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
4677
PRICE GROWTH RATING
1..100
4280
P/E GROWTH RATING
1..100
7395
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HKMPF's Valuation (9) in the null industry is somewhat better than the same rating for AMPH (65) in the Pharmaceuticals Other industry. This means that HKMPF’s stock grew somewhat faster than AMPH’s over the last 12 months.

AMPH's Profit vs Risk Rating (83) in the Pharmaceuticals Other industry is in the same range as HKMPF (100) in the null industry. This means that AMPH’s stock grew similarly to HKMPF’s over the last 12 months.

AMPH's SMR Rating (46) in the Pharmaceuticals Other industry is in the same range as HKMPF (77) in the null industry. This means that AMPH’s stock grew similarly to HKMPF’s over the last 12 months.

AMPH's Price Growth Rating (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for HKMPF (80) in the null industry. This means that AMPH’s stock grew somewhat faster than HKMPF’s over the last 12 months.

AMPH's P/E Growth Rating (73) in the Pharmaceuticals Other industry is in the same range as HKMPF (95) in the null industry. This means that AMPH’s stock grew similarly to HKMPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHHKMPF
RSI
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
32%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
44%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
31%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
30%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
29%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
39%
Advances
ODDS (%)
Bullish Trend 4 days ago
72%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
71%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
39%
Aroon
ODDS (%)
Bearish Trend 2 days ago
68%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AMPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HKMPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FWDGX12.840.01
+0.08%
American Funds Dvlpg Wld Gr&Inc 529-F-3
ECDIX18.34N/A
N/A
Eaton Vance Global Equity Income C
GMRAX12.11N/A
N/A
Nationwide Small Cap Index A
STESX16.33N/A
N/A
Bernstein International Strat Eqs SCB
FCAEX13.26N/A
N/A
Fidelity Climate Action

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with AMRX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
-1.26%
AMRX - AMPH
43%
Loosely correlated
+0.64%
COLL - AMPH
39%
Loosely correlated
+1.56%
ZTS - AMPH
33%
Loosely correlated
+0.69%
BHC - AMPH
33%
Poorly correlated
+11.05%
PAHC - AMPH
33%
Poorly correlated
+0.33%
More

HKMPF and

Correlation & Price change

A.I.dvisor tells us that HKMPF and AMPH have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKMPF and AMPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKMPF
1D Price
Change %
HKMPF100%
N/A
AMPH - HKMPF
24%
Poorly correlated
-1.26%
CAIHF - HKMPF
24%
Poorly correlated
N/A
HLTRF - HKMPF
11%
Poorly correlated
+0.27%
GRUSF - HKMPF
9%
Poorly correlated
-3.00%
ESALF - HKMPF
7%
Poorly correlated
+0.32%
More